Men's Health

The AUA has refuted findings from a recent study that reported a modest association between vasectomy and lethal prostate cancer.

The Centers for Medicare & Medicaid Services has approved two new Category I CPT codes for the UroLift system, a treatment for BPH, effective Jan. 1, 2015.

Other products featured include a 16-slice CT scanner, new generic testosterone gel, prostate cancer risk calculator, and more.

Whatever the exact mechanism of the increase in desire for testosterone replacement therapy in men, knowing the risks and benefits of testosterone and its alternatives are vital skills for today’s practicing urologist. This article will focus on alternatives to testosterone therapy.

New biomarkers for prostate cancer are showing great promise for addressing the limitations of existing diagnostic and prognostic tools, according to opinion leaders who spoke on this topic at the Large Urology Group Practice Association annual meeting in Chicago.

Magnetic resonance imaging (MRI) is a promising tool for optimizing prostate cancer biopsy that appears to overcome the shortcomings of conventional systematic transrectal ultrasound (TRUS)-guided biopsy and also provides novel information for risk stratification that can guide the decision of whether to perform biopsy, according to Samir Taneja, MD.

The American Society of Clinical Oncology has endorsed the AUA/American Society for Radiation Oncology guideline on the use of adjuvant and salvage radiotherapy after prostatectomy.

Jonathan Henderson, MD, a urologist in a large group practice in Shreveport, LA, says he and his partners have seen the nationwide proliferation of non-urologist, community-based men’s health centers. And they believe, he says, patients are not being properly served.

Two recently published studies provide new insight on cardiovascular morbidity and mortality associated with androgen deprivation therapy in men with prostate cancer.

Despite another anti-prostate cancer screening message (this one from north of the border), many U.S. urologists have already taken a more individualized approach to screening and will likely continue to do so.

A vast majority of top-ranked consumer health websites disagree with the U.S. Preventive Services Task Force’s recommendation against screening for prostate cancer, according to a study presented at the American College of Surgeons clinical congress in San Francisco.

This video demonstrates the step-by-step process, including positioning, ventral phalloplasty, and a modified “no-touch” technique, utilized in the placement of an inflatable penile prosthesis.

These videos demonstrate the difference in anatomic approach between a single penoscrotal and double perineal/penoscrotal incision technique for simultaneous placement of the inflatable penile prosthesis and artificial urinary sphincter.

This video first demonstrates the ventral phalloplasty and then shows the placement of an inflatable penile prosthesis.

This video demonstrates a technique for placing an AMS Spectra penile prosthesis (American Medical Systems) using a subcoronal incision.

This video demonstrates a unique, retractor-less approach to penoscrotal placement of the AMS 700 penile prosthesis (American Medical Systems)

The number of sexual partners a man has could be related to risk of being diagnosed with prostate cancer, Canadian researchers report.

Inflammation may be the missing link between vitamin D and prostate cancer, new study findings from the University of Colorado Cancer Center in Denver suggest.

A study presented at the American Society for Reproductive Medicine annual meeting in Honolulu suggests a possible link between the recession of 2007-2009 and increasing vasectomy rates in the United States.

Papers examining the effects of diet and substance use on male fertility presented at the recently concluded American Society for Reproductive Medicine annual meeting in Honolulu may appear to provide conflicting findings, but an expert in andrology says the observational studies don’t tell the complete story.

In this article, Robert A. Dowling, MD, reviews the challenges of implementing active surveillance in a practice as well as ways to surmount these obstacles.

In separate actions, the FDA allowed the marketing of a urinary prosthesis for women and approved a supplemental new drug application for a lymphatic mapping agent.

Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a draft local coverage determination for the Prolaris prostate cancer test, Myriad Genetics, Inc. announced.

Robot-assisted radical prostatectomy is associated with a lower rate of blood transfusion and shorter length of stay compared to open surgery. However, the total first-year reimbursement is higher for RARP and there is no difference between the two procedures in the rate of postoperative complications or use of additional cancer treatment, according to an analysis of contemporary data from the Surveillance, Epidemiology, and End Results Medicare-linked database.

A new checklist-based assessment tool could prove to be useful for surgeons learning robot-assisted radical prostatectomy.